Skip to main content
Erschienen in: Journal of Nuclear Cardiology 1/2009

01.02.2009 | Original Article

Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling

verfasst von: Nobuyuki Ohte, MD, Hitomi Narita, MD, Akihiko Iida, MD, Kazuaki Wakami, MD, Kaoru Asada, MD, Hidekatsu Fukuta, MD, Takafumi Kato, MD, Junichiro Hyano, MD, Genjiro Kimura, MD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Left ventricular (LV) remodeling occurs in the remote normal region in the LVs after myocardial infarction (MI) and is closely involved in heart failure.

Methods

We assessed myocardial oxygen consumption using a clearance rate constant K mono for the time activity curves of 11C-acetate in 15 patients with a prior anterior wall MI, 8 with a prior inferior wall MI, and 10 age-matched normal control subjects. LV end-systolic volume index (ESVI) was determined by echocardiography.

Results

The LVESVI was significantly greater in patients with an anterior and inferior MI than in control subjects. The heart rate systolic pressure product did not differ among the groups. K mono in the remote normal region in patients with an anterior MI was significantly less than that in the corresponding area in control subjects (0.055 ± 0.005 vs 0.065 ± 0.008 min−1, < .001). K mono in the remote normal region in those with an inferior MI was also significantly less compared with controls (0.054 ± 0.007 vs 0.069 ± 0.010 min−1, P < .01).

Conclusion

In patients with a prior MI and LV remodeling, myocardial oxidative metabolism is apparently impaired in the remote normal region where augmented myocardial energy production is needed against the increased end-systolic wall stress caused by LV dilatation.
Literatur
1.
2.
Zurück zum Zitat Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72.PubMed Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72.PubMed
3.
Zurück zum Zitat Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-14.PubMed Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-14.PubMed
4.
Zurück zum Zitat Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101:2981-8.PubMed Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101:2981-8.PubMed
5.
Zurück zum Zitat Ohte N, Kurokawa K, Iida A, et al. Myocardial oxidative metabolism in remote normal regions in the left ventricles with remodeling after myocardial infarction: effect of beta-adrenoceptor blockers. J Nucl Med 2002;43:780-5.PubMed Ohte N, Kurokawa K, Iida A, et al. Myocardial oxidative metabolism in remote normal regions in the left ventricles with remodeling after myocardial infarction: effect of beta-adrenoceptor blockers. J Nucl Med 2002;43:780-5.PubMed
6.
Zurück zum Zitat Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 1971;27:416-32.PubMedCrossRef Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 1971;27:416-32.PubMedCrossRef
7.
Zurück zum Zitat Porenta G, Cherry S, Czernin J, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 1999;26:1465-74.PubMedCrossRef Porenta G, Cherry S, Czernin J, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 1999;26:1465-74.PubMedCrossRef
8.
Zurück zum Zitat Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.PubMed Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.PubMed
9.
Zurück zum Zitat Nakano K, Sugawara M, Kato T, et al. Regional work of the human left ventricle calculated by wall stress and the natural logarithm of reciprocal of wall thickness. J Am Coll Cardiol 1988;12:1442-8.PubMed Nakano K, Sugawara M, Kato T, et al. Regional work of the human left ventricle calculated by wall stress and the natural logarithm of reciprocal of wall thickness. J Am Coll Cardiol 1988;12:1442-8.PubMed
10.
Zurück zum Zitat Brown MA, Myears DW, Bergmann SR. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 1988;12:1054-63.PubMed Brown MA, Myears DW, Bergmann SR. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 1988;12:1054-63.PubMed
11.
Zurück zum Zitat Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989;30:187-93.PubMed Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989;30:187-93.PubMed
12.
Zurück zum Zitat Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990;81:1594-605.PubMed Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990;81:1594-605.PubMed
13.
Zurück zum Zitat Hattori N, Tamaki N, Kudoh T, et al. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus. J Nucl Med 1998;39:1835-40.PubMed Hattori N, Tamaki N, Kudoh T, et al. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus. J Nucl Med 1998;39:1835-40.PubMed
14.
Zurück zum Zitat Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol 1990;15:528-33.PubMedCrossRef Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol 1990;15:528-33.PubMedCrossRef
15.
Zurück zum Zitat Kalkman EA, Bilgin YM, van Haren P, van Suylen RJ, Saxena PR, Schoemaker RG. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res 1996;32:1088-95.PubMedCrossRef Kalkman EA, Bilgin YM, van Haren P, van Suylen RJ, Saxena PR, Schoemaker RG. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res 1996;32:1088-95.PubMedCrossRef
16.
Zurück zum Zitat Holtz J, Restorff WV, Bard P, Bassenge E. Transmural distribution of myocardial blood flow and of coronary reserve in canine left ventricular hypertrophy. Basic Res Cardiol 1977;72:286-92.PubMedCrossRef Holtz J, Restorff WV, Bard P, Bassenge E. Transmural distribution of myocardial blood flow and of coronary reserve in canine left ventricular hypertrophy. Basic Res Cardiol 1977;72:286-92.PubMedCrossRef
17.
Zurück zum Zitat Waller C, Hiller KH, Kahler E, et al. Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart. Circulation 2001;103:1564-69.PubMed Waller C, Hiller KH, Kahler E, et al. Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart. Circulation 2001;103:1564-69.PubMed
18.
Zurück zum Zitat Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446:444-8.PubMedCrossRef Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446:444-8.PubMedCrossRef
19.
Zurück zum Zitat Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003.PubMed Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003.PubMed
20.
Zurück zum Zitat Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987;75:1130-9.PubMed Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987;75:1130-9.PubMed
21.
Zurück zum Zitat Gimelli A, Schneider-Eicke J, Neglia D, et al. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. J Am Coll Cardiol 1998;31:366-73.PubMedCrossRef Gimelli A, Schneider-Eicke J, Neglia D, et al. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy. J Am Coll Cardiol 1998;31:366-73.PubMedCrossRef
22.
Zurück zum Zitat Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994;331:222-7.PubMedCrossRef Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994;331:222-7.PubMedCrossRef
23.
Zurück zum Zitat Geshi T, Nakano A, Uzui H, et al. Relationship between impaired microvascular function in the non-infarct-related area and left-ventricular remodeling in patients with myocardial infarction. Int J Cardiol 2008;126:366-73.PubMedCrossRef Geshi T, Nakano A, Uzui H, et al. Relationship between impaired microvascular function in the non-infarct-related area and left-ventricular remodeling in patients with myocardial infarction. Int J Cardiol 2008;126:366-73.PubMedCrossRef
24.
Zurück zum Zitat Goto T, Ohte N, Miyabe H, et al. Tl-201 washout rate in remote normal regions in patients with prior myocardial infarction and left ventricular remodeling. J Nucl Cardiol 2005;12:179-85.PubMedCrossRef Goto T, Ohte N, Miyabe H, et al. Tl-201 washout rate in remote normal regions in patients with prior myocardial infarction and left ventricular remodeling. J Nucl Cardiol 2005;12:179-85.PubMedCrossRef
25.
Zurück zum Zitat Vinereanu D, Ionescu A, Fraser AG. Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart 2001;85:30-6.PubMedCrossRef Vinereanu D, Ionescu A, Fraser AG. Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart 2001;85:30-6.PubMedCrossRef
26.
Zurück zum Zitat Vinereanu D, Nicolaides E, Tweddel AC, et al. Subclinical left ventricular dysfunction in asymptomatic patients with Type 2 diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci 2003;105:591-9.PubMedCrossRef Vinereanu D, Nicolaides E, Tweddel AC, et al. Subclinical left ventricular dysfunction in asymptomatic patients with Type 2 diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci 2003;105:591-9.PubMedCrossRef
27.
Zurück zum Zitat Ohte N, Narita H, Miyabe H, et al. Evaluation of whole left ventricular systolic performance and local myocardial systolic function in patients with prior myocardial infarction using global long-axis myocardial strain. Am J Cardiol 2004;94:929-32.PubMedCrossRef Ohte N, Narita H, Miyabe H, et al. Evaluation of whole left ventricular systolic performance and local myocardial systolic function in patients with prior myocardial infarction using global long-axis myocardial strain. Am J Cardiol 2004;94:929-32.PubMedCrossRef
28.
Zurück zum Zitat Wu YW, Naya M, Tsukamoto T, et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J 2008;72:786-92.PubMedCrossRef Wu YW, Naya M, Tsukamoto T, et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J 2008;72:786-92.PubMedCrossRef
29.
Zurück zum Zitat Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.PubMedCrossRef Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.PubMedCrossRef
30.
Zurück zum Zitat Hall JL, Stanley WC, Lopaschuk GD, et al. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol 1996;271:H2320-9.PubMed Hall JL, Stanley WC, Lopaschuk GD, et al. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol 1996;271:H2320-9.PubMed
31.
Zurück zum Zitat Toyoda K, Nakano A, Fujibayashi Y, Yonekura Y, Ueda T, Lee JD. Diabetes mellitus impairs myocardial oxygen metabolism even in non-infarct-related areas in patients with acute myocardial infarction. Int J Cardiol 2007;115:297-304.PubMedCrossRef Toyoda K, Nakano A, Fujibayashi Y, Yonekura Y, Ueda T, Lee JD. Diabetes mellitus impairs myocardial oxygen metabolism even in non-infarct-related areas in patients with acute myocardial infarction. Int J Cardiol 2007;115:297-304.PubMedCrossRef
Metadaten
Titel
Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling
verfasst von
Nobuyuki Ohte, MD
Hitomi Narita, MD
Akihiko Iida, MD
Kazuaki Wakami, MD
Kaoru Asada, MD
Hidekatsu Fukuta, MD
Takafumi Kato, MD
Junichiro Hyano, MD
Genjiro Kimura, MD
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 1/2009
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-008-9006-4

Weitere Artikel der Ausgabe 1/2009

Journal of Nuclear Cardiology 1/2009 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.